These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29943811)

  • 1. Author's reply to: Implementation and organization of cancer screening in France.
    Basu P; Ponti A; Anttila A; Ronco G; Senore C; Vale DB; Segnan N; Tomatis M; Soerjomataram I; Žakelj MP; Dillner J; Elfström KM; Lönnberg S; Sankaranarayanan R
    Int J Cancer; 2018 Dec; 143(11):3035. PubMed ID: 29943811
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Screening for colorectal cancer in Taiwan and France: Does the fecal immunochemical test (FIT) fit?
    Chiu HM; Chen HH
    Cancer; 2015 Dec; 121(24):4442-3. PubMed ID: 26348401
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer screening: more information, more action, more benefits.
    Viguier J
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S2-4. PubMed ID: 21245675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact assessment of a pay-for-performance program on breast cancer screening in France using micro data.
    Sicsic J; Franc C
    Eur J Health Econ; 2017 Jun; 18(5):609-621. PubMed ID: 27329654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: colorectal cancer screening--author's reply.
    Hassan C
    Aliment Pharmacol Ther; 2013 Jan; 37(2):285. PubMed ID: 23252788
    [No Abstract]   [Full Text] [Related]  

  • 6. Author's reply to: Cancer screening policy in Hungary.
    Basu P; Ponti A; Anttila A; Ronco G; Senore C; Vale DB; Segnan N; Tomatis M; Soerjomataram I; Primic Žakelj M; Dillner J; Elfström KM; Lönnberg S; Sankaranarayanan R
    Int J Cancer; 2018 Aug; 143(4):1005. PubMed ID: 29524204
    [No Abstract]   [Full Text] [Related]  

  • 7. [From the NLST randomized trial to the clinic: how should we implement individual lung cancer screening in clinical practice?].
    Couraud S; Barlési F; Lemarié E; Zalcman G; Milleron B;
    Rev Mal Respir; 2013 Jan; 30(1):15-7. PubMed ID: 23318184
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for breast cancer screening - Author's reply.
    Miller AB
    Lancet Oncol; 2020 Nov; 21(11):514. PubMed ID: 33152287
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation and organization of cancer screening in France.
    Hamers FF; Assogba FAG; Rogel A
    Int J Cancer; 2018 Dec; 143(12):3281. PubMed ID: 29943827
    [No Abstract]   [Full Text] [Related]  

  • 10. Author's Right of Reply: Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
    Nicklin J; Morgan EL
    Aust N Z J Obstet Gynaecol; 2018 Jun; 58(3):E6. PubMed ID: 29864217
    [No Abstract]   [Full Text] [Related]  

  • 11. Author's reply to: "Detection by screening introduces biases into survival estimates for luminal A-like breast cancer patients".
    Johansson ALV; Ursin G
    Int J Cancer; 2020 Mar; 146(6):1767-1768. PubMed ID: 31576557
    [No Abstract]   [Full Text] [Related]  

  • 12. Lung cancer screening with low-dose CT: more questions than answers--author's reply.
    Mulshine JL
    Lancet Oncol; 2015 Jan; 16(1):e4. PubMed ID: 25638555
    [No Abstract]   [Full Text] [Related]  

  • 13. Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.
    de Rycke Y; Tubach F; Lafourcade A; Guillo S; Dalichampt M; Dahlab A; Bresse X; Uhart M; Bergeron C; Borne H; Cancalon C; Lajoinie A; Bénard S
    PLoS One; 2020; 15(2):e0228660. PubMed ID: 32053648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer in Taiwan and France: Does the fecal immunochemical test (FIT) fit?
    Braillon A
    Cancer; 2015 Dec; 121(24):4441-2. PubMed ID: 26348550
    [No Abstract]   [Full Text] [Related]  

  • 15. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why We Should Focus on Melanoma-Targeted Screening Strategies.
    Rat C; Dreno B; Nguyen JM
    Dermatology; 2017; 233(6):480-481. PubMed ID: 29502111
    [No Abstract]   [Full Text] [Related]  

  • 17. Excess cervical cancer screening smears: Any benefit? A retrospective cohort in Alsace, France.
    Thiery A; Akladios C; Fender M; Severac F; Baldauf JJ
    J Med Screen; 2017 Jun; 24(2):92-97. PubMed ID: 27206814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is “mobile mammography” a Relevant Method in France?].
    Vallée A
    Sante Publique; 2016 Nov; 28(5):599-602. PubMed ID: 28155735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colorectal cancer screening in primary care pharmacy in Corsica: a support for the prevention in general medicine].
    Le Duff F; Grisoni A; Filippi C; Orabona J
    Sante Publique; 2019; Vol. 31(3):387-394. PubMed ID: 31640326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.
    Leroy S; Benzaquen J; Mazzetta A; Marchand-Adam S; Padovani B; Israel-Biet D; Pison C; Chanez P; Cadranel J; Mazières J; Jounieaux V; Cohen C; Hofman V; Ilie M; Hofman P; Marquette CH;
    BMJ Open; 2017 Dec; 7(12):e018884. PubMed ID: 29282271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.